Spero Health of Ohio, LLC
Spero Health of Ohio, LLC was paid $46.00M by Medicaid between Jul 2018 and Dec 2024, across 43 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 20% of everything it billed.
ZANESVILLE, OH 43701
Next to other Substance Use Disorder Rehabilitation Clinic/Center providers in Ohio
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 55,089 | $1.45M | |
| 2019 | 108,771 | $3.28M | |
| 2020 | 121,635 | $4.03M | |
| 2021 | 172,148 | $9.24M | |
| 2022 | 203,714 | $11.37M | |
| 2023 | 156,505 | $9.87M | |
| 2024incomplete | 95,375 | $6.77M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 20% | 68,446 | 47,041 | $9.38M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 100,278 | 64,024 | $8.15M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 66,812 | 41,882 | $8.00M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9.0% | 93,892 | 52,629 | $4.15M |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 8.8% | 149,907 | 82,455 | $4.04M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 8.2% | 71,049 | 55,869 | $3.77M |
| T1003 | Lpn/lvn services, up to 15 minutes | 6.3% | 126,733 | 69,525 | $2.91M |
| H0048 | Alcohol and/or other drug testing: collection and handling only, specimens other than blood | 5.1% | 169,118 | 93,540 | $2.33M |
| H0006 | Alcohol and/or drug services; case management | 2.1% | 28,987 | 20,680 | $962K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.4% | 8,645 | 6,192 | $666K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,872 | 1,251 | $305K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 2,259 | 2,143 | $234K |
31 more codes
| H0015 | Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education | <1% | 1,722 | $201K |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 8,389 | $193K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,881 | $188K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 942 | $169K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | <1% | 1,325 | $148K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 660 | $74K |
| H0001 | Alcohol and/or drug assessment | <1% | 453 | $35K |
| 99205 | Prolong outpt/office vis | <1% | 99 | $20K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 150 | $12K |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | <1% | 407 | $9K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 110 | $8K |
| 80346 | <1% | 523 | $5K | |
| 80364 | <1% | 528 | $5K | |
| G2087 | Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month | <1% | 96 | $5K |
| 80361 | <1% | 516 | $5K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 24 | $3K |
| 80354 | <1% | 523 | $3K | |
| 80324 | <1% | 523 | $3K | |
| 80353 | <1% | 521 | $3K | |
| 80365 | <1% | 514 | $3K | |
| 80366 | <1% | 516 | $2K | |
| 80358 | <1% | 512 | $2K | |
| 80355 | <1% | 525 | $2K | |
| 80356 | <1% | 522 | $2K | |
| 80349 | <1% | 515 | $2K | |
| 80348 | <1% | 525 | $2K | |
| 90837 | Psychotherapy session, about an hour | <1% | 20 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 57 | $1K |
| 80352 | <1% | 64 | $288.61 | |
| 80359 | <1% | 65 | $244.03 | |
| 80369 | <1% | 12 | $42.44 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Spero Health of Kentucky, LLC | Danville, KY | $154.25M |
| Spero Health of Virginia, LLC | Martinsville, VA | $9.75M |
| Spero Health of Indiana, LLC | Indianapolis, IN | $8.56M |
| Tri-State Orthopaedic Surgeons, INC. | Evansville, IN | $1.09M |
| Butler Emergency Physicians Associates | Butler, PA | $398K |
| Spero Health of West Virginia, LLC | Clarksburg, WV | $391K |
| Richard M Adams DPM PA | Granbury, TX | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.